Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combined tDCS and Cognitive Training for Mild Cognitive Impairment (MCI) and Early Clinical Alzheimer's Type Dementia (CATD)

NCT04507815 is registered in ClinicalTrials.gov with Minneapolis Veterans Affairs Medical Center as lead sponsor.

NCT NCT04507815
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04507815 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combined tDCS and Cognitive Training for Mild Cognitive Impairment (MCI) and Early Clinical Alzheimer's Type Dementia (CATD)
Lead sponsor
Minneapolis Veterans Affairs Medical Center
Phase
Not applicable
Overall status
Unknown status
Start date
September 24, 2020
Completion date
September 30, 2024
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, mild cognitive impairment